TABLE 4

Pharmacokinetic parameters of sulfasalazine and effects of concomitant treatment with hypouricemic agents in Sprague-Dawley rats

Pharmacokinetic parameters were calculated using Phoenix WinNonlin. F values were calculated using the following equation: F = (AUC0–inf value of oral administration/20)/(AUC0–inf value of intravenous administration/5) × 100. Values are reported as the mean ± S.D. of three to four animals.

Test ArticleDoseCmaxT1/2AUCo–tAUCinfCLTF
mg/kgng/mlhoursngh/mlnghours/mlml/hours/kg%
0.5% MC422 ± 1821.49 ± 0.28665 ± 94713 ± 9028,395 ± 38002.0
Febuxostat203138** ± 2721.30 ± 0.135004** ± 8515012** ± 8484067** ± 60714.1
Benzbromarone501520** ± 2021.24 ± 0.462858** ± 7502888** ± 7297294** ± 19898.1
Dotinurad1.3415 ± 681.88 ± 1.56708 ± 166885 ± 26424,126 ± 77772.5
  • AUCinf, area under the plasma concentration-time curve from zero to infinity; AUC0–t, AUC at 0–12 hours; CLT, total clearance; F, bioavailability; MC, methylcellulose; T1/2, elimination half-life.

  • ** P < 0.01, significant differences from the 0.5% MC control group, as analyzed by Dunnett’s multiple comparison test.